[1]郭忠聪,龚 纯.抗癌防移片对大肠癌肝转移小鼠血清肝细胞生长因子、血管内皮生长因子表达的影响[J].陕西中医,2022,(11):1527-1530,1604.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.008]
　GUO Zhongcong,GONG Chun.Effect of Kang'ai Fangyi tablet on the expression of serum HGF and VEGF in mice with liver metastasis of colorectal cancer[J].,2022,(11):1527-1530,1604.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.008]
点击复制

抗癌防移片对大肠癌肝转移小鼠血清肝细胞生长因子、血管内皮生长因子表达的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年11期
页码:
1527-1530,1604
栏目:
基础研究
出版日期:
2022-11-05

文章信息/Info

Title:
Effect of Kang'ai Fangyi tablet on the expression of serum HGF and VEGF in mice with liver metastasis of colorectal cancer
作者:
郭忠聪; 龚 纯
(湖南中医药大学第一附属医院肿瘤科,湖南 长沙 410007)
Author(s):
GUO Zhongcong; GONG Chun
(Department of Oncology,the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine,Changsha 410007,China)
关键词:
大肠癌;  肝转移;  抗癌防移片;  抑制血管新生;  肝细胞生长因子;  血管内皮生长因子
Keywords:
Colorectal cancer;  Liver metastases;  Kang'ai Fangyi tablet;  Inhibit angiogenesis;  Hepatocyte growth factor;  Vascular endothelial growth factor
分类号:
R 735.34
DOI:
DOI:10.3969/j.issn.1000-7369.2022.11.008
文献标志码:
A
摘要:
目的:探讨抗癌防移片对大肠癌肝转移小鼠模型血清肝细胞生长因子(HGF)、血管内皮生长因子(VEGF)表达的影响。方法:采用脾脏注入CT26细胞的方法制备大肠癌小鼠模型,随机分为假手术组、模型组、抗癌防移片高剂量组、抗癌防移片低剂量组。干预4周后,ELISA法检测血清HGF、VEGF-A表达量,观察各组大肠组织及肝脏组织病理切片。结果:给药2、3、4周,与假手术组比较,其余各组小鼠体重均明显下降(P<0.05),其中模型组下降最显著(P<0.05)。与模型组比较,抗癌防移片高剂量组肝脏瘤体重量降低(P<0.05)。与假手术组比较,模型组小鼠血清CA199、CEA水平均明显升高(P<0.05)。与抗癌防移片高剂量组比较,抗癌防移片低剂量组及模型组小鼠血清CA199、CEA水平均明显升高(P<0.05)。与假手术组比较,模型组小鼠大肠组织及肝组织可见肿瘤细胞浸润; 与模型组比较,抗癌防移片高剂量组小鼠大肠组织及肝组织未见明显的肿瘤细胞,细胞形态较为规整。结论:抗癌防移片可通过下调血清HGF、VEGF表达抑制大肠癌肝转移。
Abstract:
Objective:To investigate the effect of Kang'ai Fangyi tablet on the expression of serum hepatocyte growth factor(HGF)and vascular endothelial growth factor(VEGF)in colorectal cancer liver metastasis mouse model.Methods:The colorectal cancer mouse model was prepared by injecting CT26 cells into the spleen,and divided into sham operation group,model group,high-dose Kang'ai Fangyi tablet group,and low-dose Kang'ai Fangyi tablet group randomly.After four weeks of intervention,the expressions of HGF and VEGF-A in serum were detected by ELISA,and the histopathological sections of large intestine tissue and liver tissue in each group were observed.Results:After 2,3,and 4 weeks of intervention,the weight of other groups of mice decreased significantly compared with the sham operation group(P<0.05),and the model group showed the most significant decrease(P<0.05).Compared with the model group,the liver tumor weight in the high-dose group of Kang'ai Fangyi tablet decreased(P<0.05).Compared with the sham operation group,the serum levels of CA199 and CEA in the model group were significantly increased(P<0.05).Compared with the high-dose Kang'ai Fangyi group,the serum levels of CA199 and CEA in the low-dose Kang'ai Fangyi group and model group were significantly increased(P<0.05).Compared with the sham operation group,tumor cell infiltration was seen in the large intestine and liver tissue of the mice in the model group and the low-dose Kang'ai Fangyi tablet group; no obvious tumor cells were found,cell morphology is more regular.Conclusion:Kang'ai Fangyi tablet can inhibit liver metastasis of colorectal cancer by down-regulating the expression of HGF and VEGF in serum.

参考文献/References:

[1] Lyu X,Xu X,Song A,et al.Ginsenoside rhl inhibits colorectal cancer cell migration and invasion in vitro and tumor growth in vivo[J].Oncol Lett,2019,18(4):4160-4166.
[2] Song M,Chan AT,Sun J.Influence of the gut microbiome,diet,and environment on risk of colorectal cancer[J].Gastroenterology,2020,158(2):322-340.
[3] Thanikachalam K.Colorectal cancer and nutrition[J].Nutrients,2019,11(1):164-169.
[4] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].Ca Cancer J Clin,2016,66(2):115-132.
[5] 石远凯,孙 燕.临床肿瘤内科手册[M].6版.北京:人民卫生出版社,2015:395.
[6] Gupta R,Bhatt LK,Johnston TP,et al.Colon cancer stem cells:Potential target for the treatment of colorectal cancer[J].Cancer Biol Ther,2019,20(8):1068-1082.
[7] Moris D,Pawlik TM.Personalized treatment in patients with colorectal liver metastases[J].J Surg Res,2017,216:26-29.
[8] Ohashi K,Wang Z,Yang YM,et al.NOD-like receptor C4 inflammasome regulates the growth of colon cancer liver metastasis in nafld[J].Hepatology,2019,70(5):1582-1599.
[9] Vandenhende MA,Buret J,Camou F,et al.Successful daptomycin lock therapy for implantable intraarterial catheter infection in a patient with liver metastases of colon cancer[J].Diagn Microbiol Infect Dis,2014,78(4):497-498.
[10] 郭忠聪,唐敏莉,曾柏荣.抗癌防移片治疗大肠癌肝转移疗效观察[J].中医药导报,2018,24(8):37-39.
[11] 曾柏荣,刘 华,何 欣.抗癌防移片预防Ⅲ期结肠癌术后复发转移的临床观察[J].中华中医药杂志,2008,23(7):654-655.
[12] Lugano R,Ramachandran M,Dimberg A.Tumor angiogenesis:Causes,consequences,challenges and opportunities[J].Cell Mol Life Sci,2020,77(9):1745-1770.
[13] Kontomanolis EN,Koutras A,Syllaios A,et al.Role of oncogenes and tumor-suppressor genes in carcinogenesis:A review[J].Anticancer Res,2020,40(11):6009-6015.
[14] Fu LQ,Du WL,Cai MH,et al.The roles of tumor-associated macrophages in tumor angiogenesis and metastasis[J].Cell Immunol,2020,353:104-119.
[15] Zhao C,Zhao Z,Wang Z,et al.Supervillin promotes tumor angiogenesis in liver cancer[J].Oncol Rep,2020,44(2):674-684.
[16] Husain K,Coppola D,Yang CS,et al.Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis[J].Sci Rep,2021,11(1):2185.
[17] 陈 颖.肿瘤微环境中肝星状细胞促进结直肠癌肝转移的机制研究[D].沈阳:中国医科大学,2020.
[18] 李美琴,黄玲莎.AR和HGF在大肠癌组织中的表达及其与肝转移的关系[J].中国实验诊断学,2013,17(2):318-320.
[19] Zhao L,Zhu X,Ni Y,et al.A traditional chinese medicine,inhibits the chronic restraint stress-induced liver metastasis of colon cancer in vivo[J].Pharm Biol,2020,58(1):1085-1091.
[20] 孙瑞华,蔡新生.中医药对大肠癌的精准治疗及研究进展[J].陕西中医,2019,40(11):1653-1656.
[21] 许仲宁,杨宇飞,何 斌,等.晚期结直肠癌中医治疗优势病例特点探讨分析[J].北京中医药大学学报,2015,38(4):277-279,288.
[22] 汪耔璇,李 烜.补中益气汤联合化疗治疗晚期结直肠癌临床研究[J].陕西中医,2020,41(10):1414-1417.
[23] 张晓微,杨宇慎,赵雪峰.槐果碱联合奥沙利铂对裸鼠结肠癌肝转移抑制作用的实验研究[J].陕西医学杂志,2020,49(11):1371-1374.

相似文献/References:

[1]钱朱萍,陈康海.健脾消积汤辅助化疗对大肠癌术后患者免疫功能、胃肠功能及毒副反应影响[J].陕西中医,2019,(4):487.
[2]孙瑞华,蔡新生△.中医药对大肠癌的精准治疗及研究进展*[J].陕西中医,2019,(11):1653.
[3]童玫瑰,程 千.清肠解毒方对大肠癌术后复发化疗患者〖JZ〗肿瘤标记物水平及生活质量的影响*[J].陕西中医,2020,(1):53.
　TONG Meigui,CHENG Qian..Analysis of Qingchang Jiedu decoction on quality of life and tumor markers of 〖JZ〗patients with recurrent colorectal cancer after postoperative chemotherapy[J].,2020,(11):53.
[4]罗 星,陈 琪.健脾消癌方联合化疗对大肠癌患者肿瘤标志物及预后的影响[J].陕西中医,2022,(9):1249.[doi:DOI:10.3969/j.issn.1000-7369.2022.09.023]
[5]雷 勇,杨 永,王笑民.名中医王笑民基于消燚祛瘀法治疗大肠癌便血经验[J].陕西中医,2023,(7):936.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.026]

备注/Memo

备注/Memo:
基金项目:湖南省卫生健康委员会一般项目(20200588)
更新日期/Last Update: 2022-11-09